Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Panagiotis N PapanikolaouJ P Ioannidis

Abstract

Information on major harms of medical interventions comes primarily from epidemiologic studies performed after licensing and marketing. Comparison with data from large-scale randomized trials is occasionally feasible. We compared evidence from randomized trials with that from epidemiologic studies to determine whether they give different estimates of risk for important harms of medical interventions. We targeted well-defined, specific harms of various medical interventions for which data were already available from large-scale randomized trials (> 4000 subjects). Nonrandomized studies involving at least 4000 subjects addressing these same harms were retrieved through a search of MEDLINE. We compared the relative risks and absolute risk differences for specific harms in the randomized and nonrandomized studies. Eligible nonrandomized studies were found for 15 harms for which data were available from randomized trials addressing the same harms. Comparisons of relative risks between the study types were feasible for 13 of the 15 topics, and of absolute risk differences for 8 topics. The estimated increase in relative risk differed more than 2-fold between the randomized and nonrandomized studies for 7 (54%) of the 13 topics; the e...Continue Reading

References

Mar 3, 1977·The New England Journal of Medicine·H Jick
Dec 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·R FogelholmI Kunnamo
Feb 18, 1995·BMJ : British Medical Journal·R J Cook, D L Sackett
May 1, 1996·Archives of Pediatrics & Adolescent Medicine·S RosenthalS Hadler
Oct 23, 1996·JAMA : the Journal of the American Medical Association·J C CappelleriJ Lau
Jul 11, 1997·American Journal of Medical Genetics·M M WerlerA A Mitchell
Aug 21, 1997·The New England Journal of Medicine·J LeLorierF Derderian
Feb 12, 1998·Annals of Internal Medicine·J LauC H Schmid
Apr 18, 1998·JAMA : the Journal of the American Medical Association·J P IoannidisJ Lau
May 22, 1998·Stroke; a Journal of Cerebral Circulation·R A KronmalA Newman
Mar 23, 1999·JAMA : the Journal of the American Medical Association·C M NolanS E Buskin
Sep 2, 1999·Stroke; a Journal of Cerebral Circulation·H IsoJ E Manson
Mar 4, 2000·American Journal of Medical Genetics·G C WindhamS H Swan
Jun 22, 2000·The New England Journal of Medicine·K Benson, A J Hartz
Jun 22, 2000·The New England Journal of Medicine·J ConcatoR I Horwitz
Nov 10, 2000·Lancet·I R Edwards, J K Aronson
Dec 21, 2000·The British Journal of Surgery·A HairP J O'Dwyer
Jan 9, 2001·Journal of Clinical Epidemiology·T A FurukawaS Hori
Mar 10, 2001·JAMA : the Journal of the American Medical Association·J P Ioannidis, J Lau
Apr 17, 2001·BMJ : British Medical Journal·J P IoannidisJ Lau
Aug 22, 2001·JAMA : the Journal of the American Medical Association·J P IoannidisJ Lau
Sep 21, 2001·Lancet·J GindlerUNKNOWN Jiaxing City Collaborative Project on Neural Tube Defect Prevention
Oct 23, 2001·Twin Research : the Official Journal of the International Society for Twin Studies·A EricsonA Aberg
Mar 13, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·John P A Ioannidis, Joseph Lau
May 1, 2002·JAMA : the Journal of the American Medical Association·Karen E LasserDavid H Bor
Apr 2, 2003·The American Journal of Cardiology·Phillip A HorwitzUNKNOWN Registry Committee of the Society for Cardiac Angiography Interventions
May 1, 2004·Surgery·Ulrich GullerRicardo Pietrobon
Jul 3, 2004·BMJ : British Medical Journal·Jan P Vandenbroucke
Oct 7, 2004·The American Journal of Medicine·Panagiotis N Papanikolaou, John P A Ioannidis
Oct 8, 2004·The New England Journal of Medicine·Eric J Topol
Nov 17, 2004·Annals of Internal Medicine·John P A IoannidisUNKNOWN CONSORT Group
Jul 15, 2005·JAMA : the Journal of the American Medical Association·John P A Ioannidis
Aug 3, 2005·PLoS Medicine·John P A Ioannidis

❮ Previous
Next ❯

Citations

Jul 15, 2009·Diabetologia·U Smith, E A M Gale
Apr 6, 2012·Diabetologia·J A JohnsonUNKNOWN Diabetes and Cancer Research Consortium
Jul 31, 2013·European Journal of Clinical Pharmacology·Carlos AlvesFrancisco Batel Marques
Nov 3, 2009·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Dieter GrobAnne F Mannion
Jun 7, 2013·Aging Clinical and Experimental Research·Davide BolignanoGiovanni Tripepi
Feb 10, 2009·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Haidy BibawyRichard Rosenfeld
Oct 4, 2007·International Journal of Epidemiology·Matthias EggerUNKNOWN of the STROBE group
Jul 7, 2007·BMC Medical Research Methodology·Yoon K LokeUNKNOWN Cochrane Adverse Effects Methods Group
Mar 1, 2006·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Jan P Vandenbroucke
Sep 24, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Donald A RedelmeierNick Daneman
Jul 19, 2006·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Sebastian Schneeweiss, Daniel H Solomon
Dec 21, 2012·Proceedings of the American Thoracic Society·Timothy J WiltUNKNOWN ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development
Apr 3, 2014·European Journal of Clinical Pharmacology·Carlos AlvesAna Filipa Macedo
Jan 16, 2014·Journal of Minimally Invasive Gynecology·Márlon de Freitas FonsecaClaudio P Crispi
Dec 7, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J P A IoannidisA N Freedman
May 27, 2014·Journal of Cancer Research and Clinical Oncology·Vinay Prasad
Aug 7, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Victor A Kiri
Jan 15, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Preciosa M ColomaGianluca Trifirò
Feb 5, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Preciosa M ColomaMiriam Sturkenboom
Jul 18, 2008·Epidemiology·John P A Ioannidis
Jul 31, 2013·The Journal of Nervous and Mental Disease·Daniel J Safer, Julie M Zito
Aug 16, 2006·Expert Opinion on Drug Safety·Mark Jones, Chis Del Mar
Apr 26, 2015·Journal of Clinical Epidemiology·Spyridon N PapageorgiouMartyn T Cobourne
Aug 24, 2013·Diabetes Research and Clinical Practice·Aissa Boudiba
Jan 5, 2016·Journal of Evaluation in Clinical Practice·Shashi S Seshia
Sep 18, 2015·Pharmacoepidemiology and Drug Safety·Diogo MendesFrancisco Batel-Marques

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved